·bpc-157

How to Reconstitute BPC-157: Step-by-Step Visual Guide

A research-focused walkthrough for reconstituting BPC-157 peptide from lyophilized powder using bacteriostatic water, covering standard vial sizes of 5 mg with dose ranges commonly used in preclinical studies (250–500 mcg per administration).

By Pepticker Editorial, Pepticker editorial teamEducational overview · not yet clinician-reviewed
Awaiting medical review

Materials Needed

Before beginning reconstitution, gather the following materials in a clean workspace. Researchers should use sterile technique throughout. Required items include: one vial of lyophilized BPC-157 powder (typically 5 mg), one vial of bacteriostatic water (BAC water, 30 mL), insulin syringes (U-100, 1 mL with 29–31 gauge needle), alcohol prep pads (70% isopropyl), a sharps disposal container, and exam gloves. Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, extending the stability of the reconstituted peptide under refrigeration. Sterile water for injection is an acceptable substitute but reduces shelf life significantly.

[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop

Calculating BAC Water Volume

The volume of BAC water added determines the concentration of the final solution. For BPC-157 research, a common target concentration is 500 mcg/mL (0.5 mg/mL), which makes dose math straightforward on a U-100 insulin syringe.

Worked example: Starting with a 5 mg vial and targeting 500 mcg/mL — divide total peptide mass by target concentration: 5 mg ÷ 0.5 mg/mL = 10 mL of BAC water. Adding 10 mL yields exactly 500 mcg per mL. Alternatively, adding 2 mL yields 2,500 mcg/mL (a more concentrated solution requiring smaller injection volumes). Choose concentration based on the injection volume that is practical for the delivery route under study.

[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop

Reconstitution Steps

Step 1 — Swab both vial stoppers with an alcohol pad and allow to air-dry for 30 seconds. This reduces particulate and microbial contamination at the injection site.

[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop

Step 2 — Draw the calculated volume of BAC water (e.g., 10 mL drawn in multiple syringe fills if using a 1 mL syringe) into the syringe.

[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop

Step 3 — Insert the needle into the BPC-157 vial and slowly inject the BAC water down the inner wall of the vial, not directly onto the powder cake. This minimizes protein denaturation from shear forces.

[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop

Step 4 — Gently swirl (do not shake) the vial in slow circular motions until the powder is fully dissolved. The solution should appear clear and colorless. If the solution remains cloudy after 60 seconds of swirling, allow the vial to rest for 5 minutes and swirl again.

[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop

Step 5 — Inspect the solution visually. It should be clear, free of particles, and colorless to very slightly yellow. Do not use if the solution is opaque, has visible particulates, or has an unusual color.

Calculating Units on Syringe per Dose

A U-100 insulin syringe marks 100 units per mL, where 1 unit = 0.01 mL. Using the example concentration of 500 mcg/mL:

For a 250 mcg research dose: 250 mcg ÷ 500 mcg/mL = 0.5 mL = 50 units on the syringe.

For a 500 mcg research dose: 500 mcg ÷ 500 mcg/mL = 1.0 mL = 100 units on the syringe.

[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop

Storage After Reconstitution

Store the reconstituted BPC-157 vial in a standard laboratory or household refrigerator at 2–8°C (36–46°F). When reconstituted in BAC water, the solution is stable for approximately 4–6 weeks under refrigeration. Do not freeze reconstituted peptide — freeze-thaw cycles disrupt the peptide structure. Keep the vial in a dark location or wrap in foil as light can degrade peptide bonds over time. Label the vial with the reconstitution date and calculated concentration.

Safety Notes and Research Framing

BPC-157 (Body Protection Compound-157) is a synthetic pentadecapeptide derived from a protective protein found in gastric juice. It is an active area of preclinical research investigating wound healing, tendon-to-bone repair, and gastrointestinal mucosal protection. All information in this guide is intended strictly for research contexts. BPC-157 is not approved by the FDA for human therapeutic use and has not completed Phase III clinical trials. Researchers should observe standard laboratory safety protocols, maintain sterile technique, use appropriate personal protective equipment, and store, handle, and dispose of materials in accordance with institutional guidelines.

[@portabletext/react] Unknown block type "callout", specify a component for it in the `components.types` prop
Frequently asked
What concentration should BPC-157 be reconstituted to for research use?
A common research concentration is 500 mcg/mL, achieved by adding 10 mL of BAC water to a 5 mg vial. This allows easy syringe dosing in 0.1 mL increments equivalent to 50 mcg per step.
How long is reconstituted BPC-157 stable?
When reconstituted in bacteriostatic water and stored at 2–8°C, BPC-157 solution is generally considered stable for 4–6 weeks. Lyophilized powder stored dry and refrigerated may retain potency for 2+ years.
Can BPC-157 be frozen after reconstitution?
Freezing reconstituted peptide is not recommended. Freeze-thaw cycles can disrupt peptide structure and reduce potency. Store the reconstituted vial at refrigerator temperature only.
Why must the BAC water be injected along the vial wall?
Directing the liquid stream directly onto the lyophilized powder cake can mechanically denature the peptide through shear forces. Allowing the BAC water to run gently down the inner glass wall minimizes this risk.
Is BPC-157 approved for human use?
No. BPC-157 is not approved by the FDA for human therapeutic use. It is available for research purposes only and has not completed the clinical trial process required for regulatory approval.
Citations
  1. Chang CH et al. BPC 157 and tendon healing. J Appl Physiol. 2011;110(3):774-80.. https://pubmed.ncbi.nlm.nih.gov/21071588/
  2. Sikiric P et al. Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract. Curr Pharm Des. 2011;17(16):1612-32.. https://pubmed.ncbi.nlm.nih.gov/21548867/
  3. FDA. Bacteriostatic Water for Injection USP label.. https://www.accessdata.fda.gov/drugsatfda_docs/label/2004/016831s029lbl.pdf

Was this guide helpful?